Sponsor
University of Arizona
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name University of Arizona appears in 173 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownBreathing for Two: Inspiratory Muscle Strength Training for Supporting Healthy Blood Pressure in PregnancyNCT07687745 · lead sponsor · 2026-06-08
RECRUITINGSymptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their CaregiversNCT07415564 · lead sponsor · 2026-05-06
RECRUITINGSocial Optimization StudyNCT07564960 · lead sponsor · 2026-04-27
RECRUITINGThe Impact of Exercise on the Tumor Microenvironment in Patients With Lung CancerNCT07216209 · lead sponsor · 2026-01-13
RECRUITINGRadiation Combined With BIspecific T-Cell Engager in DLL3 Expressing TumorsNCT06814496 · lead sponsor · 2025-09-08
RECRUITINGHigh-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)NCT03954431 · lead sponsor · 2025-08-14
RECRUITINGRemote tDCS and Chair Yoga for Chronic Knee Pain in Alzheimer's PatientsNCT07303998 · lead sponsor · 2025-03-04
RECRUITINGbpMedManage: Digital Technology to Support Adherence to Hypertension MedicationsNCT06307574 · lead sponsor · 2024-02-29
RECRUITINGThe Breast Cancer Survivors and Partners Online Research Together (SUPORT) ProjectNCT05676255 · lead sponsor · 2023-03-20
RECRUITINGWellness Intervention for Smoking and HIVNCT04725617 · lead sponsor · 2021-11-16
RECRUITINGTrial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAHNCT04062565 · lead sponsor · 2019-03-25
RECRUITINGInhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin ResistanceNCT04062890 · lead sponsor · 2030-04-15
WITHDRAWNPilot Feasibility Study of a Dyadic Culinary Nutrition InterventionNCT07702864 · lead sponsor · 2027-01-01
NOT_YET_RECRUITINGUtility of Adding MR Fusion to Standard US Guided Prostate BiopsyNCT05064111 · lead sponsor · 2026-11-01
SUSPENDEDMIND-WELL InterventionNCT07839325 · lead sponsor · 2026-09-01
NOT_YET_RECRUITINGClinical Feasibility Study of Upright, Low-dose, High-resolution, 3D Breast CT (UBCT).NCT07705100 · lead sponsor · 2026-08-01
NOT_YET_RECRUITINGMechanistic Underpinnings of PreeclampsiaNCT06567899 · lead sponsor · 2026-07-25
NOT_YET_RECRUITINGImpact of Continuous Glucose Monitoring and Education Intervention on Glycemic Control and Behavioral Changes in Pre-Diabetic AdolescentsNCT07569185 · lead sponsor · 2026-06-01
NOT_YET_RECRUITINGGlymphatic Function TMS StudyNCT07192913 · lead sponsor · 2026-01-01
NOT_YET_RECRUITINGPulmonary Hypertension Inspiratory TrainingNCT06931886 · lead sponsor · 2025-10-25
ENROLLING_BY_INVITATIONCulturally Tailored Nutrition Therapy to Improve Dietary Adherence of Type 2 Diabetes Patients in Benin, AfricaNCT07145684 · lead sponsor · 2025-09-08
ACTIVE_NOT_RECRUITINGImpact of Osteopathic Manipulative Medicine on Sentinal Lymph Node Biopsy Dye and Tracer UptakeNCT07269860 · lead sponsor · 2025-07-09
COMPLETEDReduced Volume of Inspiratory Resistance TrainingNCT05744817 · lead sponsor · 2024-06-13
WITHDRAWNEvaluation of Hydroxychloroquine to Prevent CIPNNCT05689359 · lead sponsor · 2024-06-01
WITHDRAWNFitbit Device Use in Overweight PregnancyNCT06226597 · lead sponsor · 2024-02-08
ACTIVE_NOT_RECRUITINGA Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American MenNCT04186260 · lead sponsor · 2024-02-05
COMPLETEDDiabetes Self-Management Plus Tai Chi EasyNCT06180655 · lead sponsor · 2024-01-31
COMPLETEDCarbonic Anhydrase Inhibitors and Carbonation: A Novel Approach to Reduce Soda ConsumptionNCT06110078 · lead sponsor · 2024-01-18
UNKNOWNHispanic Adapted and Culturally Relevant Exercising TogetherNCT06018311 · lead sponsor · 2023-11-01
ACTIVE_NOT_RECRUITINGFood and Resources Expanded to Support Health and Type 2 DiabetesNCT06211270 · lead sponsor · 2023-09-13
ENROLLING_BY_INVITATIONMy Interprofessional Care Team for Adherence and Research Engagement DisparitiesNCT05470439 · lead sponsor · 2023-08-30
ACTIVE_NOT_RECRUITINGAllopregnanolone Regenerative Therapeutic for Mild Alzheimer's DiseaseNCT04838301 · lead sponsor · 2023-08-15
ACTIVE_NOT_RECRUITINGInspiratory Muscle Strength Training in Adults With Type 2 DiabetesNCT05643768 · lead sponsor · 2023-06-30
COMPLETEDAdaptive Symptom Self-Management Immunotherapy StudyNCT05715255 · lead sponsor · 2023-05-08
ACTIVE_NOT_RECRUITINGAltering Default Mode Network Activity With Transcranial Focused Ultrasound to Reduce Depressive SymptomsNCT06320028 · lead sponsor · 2023-04-27
UNKNOWNASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections Among People Who Inject DrugsNCT05270135 · lead sponsor · 2022-12-01
COMPLETEDNovel Thermal Imaging Technique for Breast ScreeningNCT05650086 · lead sponsor · 2022-11-15
TERMINATEDImproving Hypertension Medication Adherence for Older AdultsNCT05610059 · lead sponsor · 2022-11-02
COMPLETEDEpigenetics of TNBC in Overweight and Obese Hispanic & Non-Hispanic White WomenNCT04291950 · lead sponsor · 2022-08-30
WITHDRAWNLiquid Biopsy for Early Non-small Lung Cancer DetectionNCT05462795 · lead sponsor · 2022-08-02
COMPLETEDDedicated Breast CT for Quantitative Breast Density Measurements in Mexican-origin Women in Southern ArizonaNCT04799665 · lead sponsor · 2022-04-28
COMPLETEDVentilation and Perfusion Scan in Pulmonary Embolism Following Catheter Directed Thrombectomy Versus Anticoagulation AloneNCT05133713 · lead sponsor · 2022-04-01
UNKNOWNBiomarker Study: Heart Failure Patients at RiskNCT05336175 · lead sponsor · 2022-04-01
UNKNOWNWeight Loss in Primary Care With Targeted Education and Frequent Follow UpsNCT05141084 · lead sponsor · 2021-12-01
UNKNOWNAZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency DepartmentNCT04669288 · lead sponsor · 2021-11-22
TERMINATEDBreathing Training for Improving Cardiovascular Health in Older Adults With Sleep ApneaNCT04932447 · lead sponsor · 2021-09-01
ACTIVE_NOT_RECRUITINGImmune Response to the COVID-19 VaccineNCT04936997 · lead sponsor · 2021-06-07
COMPLETEDSulfasalazine in Decreasing Opioids Requirements in Breast Cancer PatientsNCT03847311 · lead sponsor · 2021-05-03
COMPLETEDProspective Comparison of Breast MRI vs Contrast Mammography Prior to Surgery in Breast Cancer PatientsNCT04770714 · lead sponsor · 2021-01-19
WITHDRAWNComprehensive Lifestyle Improvement Program for Men With Prostate Cancer2 (CLIPP2)NCT04228055 · lead sponsor · 2020-08-07
UNKNOWNAllopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular StudyNCT03748303 · lead sponsor · 2019-10-01
TERMINATEDTesting the Effect of Multiple Weight Management Modalities for Chronic Disease Risk Reduction in a Clinical SettingNCT03998878 · lead sponsor · 2019-08-08
COMPLETEDED-Initiated School-based Asthma Medication SupervisionNCT03952286 · lead sponsor · 2019-08-01
COMPLETEDPhase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson's DiseaseNCT06021756 · lead sponsor · 2019-07-28
UNKNOWNMitochondrial Methylation in Type 2 DiabetesNCT04126551 · lead sponsor · 2019-07-23
COMPLETEDEffect of Servo-Ventilation on CO2 Regulation and Heart Rate VariabilityNCT03890939 · lead sponsor · 2019-07-15
UNKNOWNType 2 Diabetes Prevention in Community Health Care Settings for at Risk Children and MothersNCT03781102 · lead sponsor · 2019-07-01
TERMINATEDWindow of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast TumorsNCT03911453 · lead sponsor · 2019-04-19
COMPLETEDThe Impact of Pregnancy and Pregnancy-associated Hypertension on Human Uterine Myometrial Artery ReactivityNCT03888170 · lead sponsor · 2019-04-01
WITHDRAWNPilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone MetsNCT03661892 · lead sponsor · 2018-12-19
COMPLETEDDrugs studied in this sponsor's trials
37 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing University of Arizona as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
acetazolamide1
anastrozole1
azithromycin1
belatacept1
bevacizumab1
carboplatin1
cyclophosphamide1
dexamethasone1
acetazolamide RxCUI 167 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
anastrozole RxCUI 84857 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
azithromycin RxCUI 18631 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
belatacept RxCUI 1112973 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
bevacizumab RxCUI 253337 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
carboplatin RxCUI 40048 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
cyclophosphamide RxCUI 3002 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
dexamethasone RxCUI 3264 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
duloxetine RxCUI 72625 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
estradiol RxCUI 4083 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
etoposide RxCUI 4179 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
everolimus RxCUI 141704 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
exemestane RxCUI 258494 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
finasteride RxCUI 25025 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
fluorouracil RxCUI 4492 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
flutamide RxCUI 4508 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
hydroxychloroquine RxCUI 5521 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
imiquimod RxCUI 59943 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
irinotecan hydrochloride RxCUI 153329 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
metformin RxCUI 6809 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
mitoxantrone hydrochloride RxCUI 203129 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
olanzapine RxCUI 61381 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
oxytocin RxCUI 7824 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
paclitaxel RxCUI 56946 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
Sponsor roles
lead sponsor139
collaborator34
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.